FDA issues rules for sterile compounding pharmacies
NEW YORK — Compounding pharmacies that produce sterile drugs can register as outsourcing facilities and may be exempt from certain Food and Drug Administration approval requirements, according to a document published on the FDA’s website.
The document, issued under the Drug Quality and Security Act, signed into law last week by president Barack Obama, states that once a sterile compounding pharmacy has been registered as an outsourcing facility, it must meet certain conditions in order to be exempt from the Federal Food, Drug and Cosmetic Act’s approval requirements and the requirement to label products with adequate directions for use. The drugs must be compounded in compliance with the agency-defined current good manufacturing practices, or CGMP, either by licensed pharmacist or under the pharmacist’s supervision.
The outsourcing facility must also report information such as a list of all products compounded during the past six months and where it got the ingredients it used to compound, as well as reporting adverse side effects.
Twitter sheds light on college students’ med misuse
MOUNT PROSPECT, Ill. — College students are using popular social media platform Twitter to talk about prescription drugs, and it turns out those brief, 140-character messages are saying a lot about medication abuse and misuse, according to the National Association of Boards of Pharmacy.
Researchers from the University of Pennsylvania monitored over 2,000 tweets over a one-week period and discovered that 60% to 70% of the tweets mentioned drug abuse and medication misuse.
Another study from Brigham Young University analyzed over 213,000 tweets over the period of Nov. 2011 to May 2012, all of which mentioned the word “Adderall.” The study revealed that mentions of the drug increased during college exam periods, shedding even more light on the fact that a great deal of students use the drug with the intention of increasing their concentration and productivity during exam time.
Fruth Pharmacy promotes Tim Weber to VP
POINT PLEASANT, W.Va. — Fruth Pharmacy has promoted director of pharmacy administration and procurement Tim Weber to VP, the regional retail pharmacy chain said Thursday.
In the new position, Weber will lead the chain’s pharmacy division. He previously held positions at Eckerd Drug Company and Sears Holdings.
"One of our best successes to date is our migration from legacy PDX to a workflow-orientated Enterprise Pharmacy System," Weber said. "This system enables Fruth to optimize the filling process and gives our pharmacy teams more functionality within the daily workflow to better serve our patients. Fruth has been able to advance our clinical services to our patients due to this improvement by integrating medication therapy management into the pharmacy workflow."